| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.0021 | 0.9 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.002 | 0.9 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.0039 | 1 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |